Literature DB >> 308384

Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.

C T Giambalvo, S R Snodgrass.   

Abstract

Unilateral injections of the serotonin neurotoxin, 5,7-dihydroxytryptamine (DHT), at various points along the 5-HT pathway to the forebrain produce a turning syndrome associated with alterations of dopamine synthesis in the ipsilateral striatum. Unilateral injections of DHT into the SN produced an ipsilateral increase in striatal dopamine (DA) turnover and contralateral rotation in response to amphetamine or apomorphine. Injection of DHT into the MFB produced an ipsilateral decrease in striatal DA turnover and tyrosine hydroxylase (TOH) activity, and ipsilateral rotation in response to amphetamine or apomorphine. After the injection of DHT into the SN or MFB, there was a significant correlation between the rates of drug-induced rotation, the decrease in cortical 5-HT turnover, and the change in striatal DA turnover, suggesting that the unilateral change in DA turnover (and, presumably, the increased stimulation of DA receptors) is causally linked to turning. Injection of DHT into the zones of the striatum and GP richest in 5-HT terminals produced the same responses as the MFB-lesioned rats: ipsilateral rotation and a decrease in striatal TOH activity. Injection of DHT into the area of the striatum richest in DA terminals failed to produce rotation or a significant change in TOH activity. We suggest that 5-HT neurons from the raphe nuclei exert a tonic inhibition on the nigrostriatal pathway at the level of the SN through direct synapses on DA neurons, whereas their neostriatal terminals have an indirect effect on DA terminals, perhaps via interaction with cholinergic and GABA-ergic neurons.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308384     DOI: 10.1016/0006-8993(78)91110-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.

Authors:  K Gale; M Casu
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

2.  Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function.

Authors:  M G Palfreyman; C J Schmidt; S M Sorensen; M W Dudley; J H Kehne; P Moser; M W Gittos; A A Carr
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.

Authors:  D S Charney; S W Woods; W K Goodman; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 4.  Presynaptic control of serotonin on striatal dopamine function.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Psychopharmacology (Berl)       Date:  2010-10-16       Impact factor: 4.530

5.  Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat.

Authors:  M H Thiébot; P Soubrié; M Hamon; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices.

Authors:  B Nurse; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1988-05       Impact factor: 3.996

7.  Brain monoamine metabolism and rotational behaviour induced by experimental herpes simplex virus encephalitis.

Authors:  M A Päivärinta; R J Marttila; M Koulu; U Pesonen; M Röyttä; U K Rinne
Journal:  J Neural Transm Gen Sect       Date:  1991
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.